Left ventricular hypertrophy: A rare cardiac involvement of Becker muscular dystrophy  by Kang, Yu et al.
Kaohsiung Journal of Medical Sciences (2016) 32, 533e534Available online at www.sciencedirect.com
ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORLeft ventricular hypertrophy: A rare cardiac
involvement of Becker muscular dystrophyDear Editor,
Due to a different mutation site in the Duchenne muscular
dystrophy (DMD) gene, patients with Becker muscular dys-
trophy (BMD) show a milder and slower clinical progression
as compared with patients with DMD. Cardiac involvement
is a frequent feature of both dystrophies, which can
develop before or after skeletal muscle damage. Asymp-
tomatic cardiomyopathy is seen in most cases, and left- or
bi-ventricular dilation occurs in up to one-third of patients
with BMD [1]. In contrast, left ventricular (LV) hypertrophy
has rarely been reported.
A 32-year-old male patient was admitted with the chief
complaint of exertional dyspnea and fatigue accompanied
by mild muscular pain and weakness in the lower extrem-
ities for 2 years. Mildly enlarged cardiac dullness, pseudo-
hypertrophy of the calf muscles, Gowers sign, and mild
muscular weakness and tenderness in the lower extremities
were present on physical examination.
Laboratory tests showed very high levels of myogenic
and myocardiogenic enzymes, including a cytokinase (CK)
of 4730 IU/L (normal range: 19e226 IU/L), lactate dehy-
drogenase of 838 IU/L (110e220 IU/L), myoglobin of
966 ng/mL (28e72 ng/mL), CK-MB > 300 ng/L (< 4.94 ng/
L), and Troponin-T of 80 ng/L (< 14 ng/L). The level of
serum N-terminal-pro-brain natriuretic peptide was 512 pg/
mL (0e88 pg/ml). The echocardiogram (ECG) demonstrated
LV hypertrophy with increased R-wave amplitude and
inverted T-wave in the left-sided ECG leads (V5, V6, I, and
AVL). Two-dimensional echocardiography revealed severe
LV hypertrophy, normal LV end-diastolic dimensions, and a
preserved LV-ejection fraction. Neither an outflow tract
obstruction nor mitral leaflet systolic anterior motion was
detected (Figure 1A). Moreover, delayed enhancement of
the myocardium was detected by cardiac magnetic reso-
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quently, a skeletal muscle biopsy with specific immunohis-
tochemistry showed positive expression of dysferlin and a,
b, g, and d-sarcoglycan, but the intensity indicated
decreased N-terminal, C-terminal, and rod-domain dystro-
phin, which helped to confirm BMD (Figure 1C as compared
to normal skeletal muscle cells from another patient shown
in Figure 1D; informed consent was obtained from the pa-
tients to publish their data). Unfortunately, this patient
refused genetic testing.
X-linked DMD and BMD are allelic disorders caused by
mutations in the DMD gene. The gene mainly encodes dys-
trophin, which is primarily localized at the surface mem-
brane of striated muscle fibers and is expressed in similar
isoforms in skeletal, cardiac, and smooth muscle. In DMD,
dystrophin is nearly absent. Severe skeletal muscle
involvement occurs at a very young age and rapidly pro-
gresses to akinesia within a few years. In contrast, dystro-
phin remains present at some concentration, but shows an
abnormal phenotype in BMD [1]. Similar to this case, BMD
patients usually present later in life, with mild skeletal
muscular symptoms of slower progression; however, these
patients usually have obvious symptoms of cardiac
involvement.
Because a dystrophin deficiency makes muscular cells
vulnerable to the damage caused by mechanical stress,
necrotic myocytes are replaced by connective tissue fibers
and fat [2]. However, there is great variability in the degree
of cardiac involvement in BMD. As previously reported,
different types of ECG abnormalities are frequently
observed in BMD. Not surprisingly, morphological changes in
the myocardium usually manifest as LV or biventricular
chamber dilation [3]. Delayed gadolinium enhancement in
the dilated LV via CMR was also reported [4]. In contrast, LV
hypertrophy (as in this case) is extremely rare in both BMD
and DMD. There was one case reported of a 17-year-old boy
with BMD who presented with a rapid progression from
hypertrophic cardiomyopathy to heart failure within 2 years
[5]. Therefore, myopathy should be considered when LVy Elsevier Taiwan LLC. This is an open access article under the CC
).
Figure 1. (A) Hypertrophic IVS and LVPW at the parasternal long-axis view by echocardiography. (B) Hypertrophic anterior
septum with delayed gadolinium enhancement (arrow) at the long-axis two-chamber view by cardiac magnetic resonance. (C)
Longitudinal section of skeletal muscle cells from this patient, showing negative C-terminal dystrophin at most of the muscle cell
membranes (black arrow) and C-terminal dystrophin with abnormal phenotype at a few sites (white arrow) by immunohisto-
chemical staining (200). (D) As a reference, cross-section of normal skeletal muscle cells from the amputated limb of a patient
with traffic injury, showing uniform and intense C-terminal dystrophin at every muscle cell membrane (white arrow) by immu-
nohistochemical staining (200). IVS Z interventricular septum; LVPW Z left-ventricular posterior wall.
534 Letter to the Editorhypertrophy is accompanied by myalgia, difficulty in mov-
ing, and increased myogenic enzymes. Muscle biopsy and
genetic testing may help confirm the diagnosis.
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